CLARITY Act Stalls in Senate, Industry Players Left Waiting

The CLARITY Act, a bill aimed at regulating prediction markets in the US, has stalled in the Senate and is now expected to be taken up in September. The delay has sparked concerns among industry players, who had been hoping for clarity on the regulatory framework for these emerging markets.

One of the key issues holding up the bill is a standoff between the Department of Justice (DOJ) and state attorneys general over ethics standards for prediction market operators. Additionally, there are disputes over consumer protection measures, including the regulation of BRCA developers.

The delay has also led to concerns about the potential impact on the industry's growth and development. The SEC and CFTC have reportedly developed a 'Plan B' in case Congress fails to pass the bill, which would involve implementing rules to regulate prediction markets without legislative approval.